The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Supporting students with complex needs in inclusive classrooms
Canada’s military readiness worsening, report finds
Warnings of disinformation campaigns as AI-made videos improve
Paying for Canada’s pharmacare plan
Why a bald eagle nest in Toronto is exciting conservationists
Why Indian day school survivors are challenging the settlement compensation process
With historical films leading the Oscars, filmmakers are drawing on the past
What Trump’s Super Tuesday success means for the 2024 U.S. election
Dr. Sima Samar on fighting for women’s rights in Afghanistan
Pussy Riot’s Masha Alyokhina reflects on death of Alexei Navalny
Couple finds joy in everyday life, despite Alzheimer’s
New book explores solutions for Canada’s housing crisis
How ocean sound pollution is endangering baleen whales
What Super Tuesday could mean for the 2024 U.S. election
Yuval Noah Harari on achieving peace in Gaza
How hospitals, long-term care impact older adults
Afghan migrants in Pakistan fear crackdown by authorities
Regulating overcrowded rooming houses in Brampton, Ont.
Warnings over measles as some officials fear spread in Canada
Remembering former prime minister Brian Mulroney
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly